1. Home
  2. BVS vs NLOP Comparison

BVS vs NLOP Comparison

Compare BVS & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • NLOP
  • Stock Information
  • Founded
  • BVS 2011
  • NLOP N/A
  • Country
  • BVS United States
  • NLOP United States
  • Employees
  • BVS N/A
  • NLOP N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NLOP
  • Sector
  • BVS Health Care
  • NLOP
  • Exchange
  • BVS Nasdaq
  • NLOP Nasdaq
  • Market Cap
  • BVS 448.8M
  • NLOP 498.8M
  • IPO Year
  • BVS 2021
  • NLOP N/A
  • Fundamental
  • Price
  • BVS $6.67
  • NLOP $29.31
  • Analyst Decision
  • BVS Strong Buy
  • NLOP Strong Buy
  • Analyst Count
  • BVS 4
  • NLOP 1
  • Target Price
  • BVS $13.75
  • NLOP $46.00
  • AVG Volume (30 Days)
  • BVS 291.4K
  • NLOP 88.4K
  • Earning Date
  • BVS 11-04-2025
  • NLOP 11-19-2025
  • Dividend Yield
  • BVS N/A
  • NLOP 10.64%
  • EPS Growth
  • BVS N/A
  • NLOP N/A
  • EPS
  • BVS 0.03
  • NLOP N/A
  • Revenue
  • BVS $564,142,000.00
  • NLOP $117,598,000.00
  • Revenue This Year
  • BVS N/A
  • NLOP N/A
  • Revenue Next Year
  • BVS $6.88
  • NLOP N/A
  • P/E Ratio
  • BVS $237.41
  • NLOP N/A
  • Revenue Growth
  • BVS 5.08
  • NLOP N/A
  • 52 Week Low
  • BVS $5.81
  • NLOP $26.10
  • 52 Week High
  • BVS $14.38
  • NLOP $34.53
  • Technical
  • Relative Strength Index (RSI)
  • BVS 45.07
  • NLOP 44.23
  • Support Level
  • BVS $6.37
  • NLOP $28.60
  • Resistance Level
  • BVS $6.83
  • NLOP $29.24
  • Average True Range (ATR)
  • BVS 0.25
  • NLOP 0.49
  • MACD
  • BVS -0.02
  • NLOP 0.03
  • Stochastic Oscillator
  • BVS 44.63
  • NLOP 40.44

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About NLOP Net Lease Office Properties of Beneficial Interest

Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns a diversified portfolio of office properties that are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its net leases generally specify a base rent with rent increases and require the tenant to pay substantially all costs associated with operating and maintaining the property. Its portfolio includes approximately 1.2 million square feet of Green-Certified Buildings, 2 LEED-certified buildings, and 1 BREEAM-certified building.

Share on Social Networks: